Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China

Objectives The main aim of this study was to investigate the prevalence and molecular characteristics of the mcr-1 gene in Escherichia coli isolates obtained from all patients with bloodstream infections over a year in a Chinese teaching hospital. We also assessed the susceptibility profiles of the mcr-1-positive strains and prognostic impact of this gene on the patients. Methods A total of 144 consecutive, non-repetitive E. coli isolates causing bloodstream infections were collected at a teaching hospital in Changsha, China from January to December 2016. The presence of the mcr-1 gene was assessed by PCR. All mcr-1-positive E coli isolates were characterized by antimicrobial susceptibility testing, multilocus sequence typing (MLST), a conjugation experiment, and plasmid replicon typing. Clinical data were obtained from medical records. Results The mcr-1 gene was detected in three (2.1%) of the 144 E. coli isolates. The three mcr-1-positive E. coli isolates were resistant to colistin. All three isolates showed a lower resistance to other classes of antibacterials, with all three being susceptible to carbapenems. The MLST results indicated that the three E. coli isolates were assigned to three different sequence types: ST457, ST101, and ST1413, respectively. The conjugation experiment showed that the mcr-1 gene was successfully transferred to the recipient (E. coli EC600) from two isolates, one of which possessed IncI1 replicons and the other of which carried IncHI2 and IncN replicons. The patients with bloodstream infections caused by mcr-1-positive isolates had severe underlying diseases and were cured after antibacterial treatment. Conclusion The prevalence of the mcr-1 gene in patients with E. coli bloodstream infection was 2.1% in Changsha, China. The mcr-1-positive E. coli isolates had varied susceptibility profiles, although all three were susceptible to carbapenems. This therapeutic window is crucial given the risk of rapid deterioration in high-incidence areas worldwide.

[1]  H. Shan,et al.  Colistin-Resistant mcr-Positive Enterobacteriaceae in Fresh Vegetables, an Increasing Infectious Threat in China. , 2019, International journal of antimicrobial agents.

[2]  Shangshang Qin,et al.  Characterization of a novel blaNDM-5-harboring IncFII plasmid and an mcr-1-bearing IncI2 plasmid in a single Escherichia coli ST167 clinical isolate , 2019, Infection and drug resistance.

[3]  M. Zou,et al.  Characterization of Highly Prevalent Plasmids Coharboring mcr-1, oqxAB, and blaCTX-M and Plasmids Harboring oqxAB and blaCTX-M in Escherichia coli Isolates from Food-Producing Animals in China. , 2019, Microbial drug resistance.

[4]  Yan Liu,et al.  Transmission of mcr-1-Producing Multidrug-resistant Enterobacteriaceae in Public Transportation in Guangzhou, China. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Yi-Tsung Lin,et al.  Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan. , 2018, International journal of antimicrobial agents.

[6]  Xuemei Li,et al.  Prevalence and molecular characteristics of mcr-1 colistin resistance in Escherichia coli: isolates of clinical infection from a Chinese University Hospital , 2018, Infection and drug resistance.

[7]  Jing-Ping Liu,et al.  Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature , 2018, Front. Neurol..

[8]  Shaolin Wang,et al.  Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008–2014 , 2018, Emerging Microbes & Infections.

[9]  A. Walker,et al.  High Rates of Human Fecal Carriage of mcr-1–Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Yonghong Xiao,et al.  Complete genome sequencing and genomic characterization of two Escherichia coli strains co-producing MCR-1 and NDM-1 from bloodstream infection , 2017, Scientific Reports.

[11]  J. Setubal,et al.  Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? , 2017, Clinics.

[12]  K. Kristóf,et al.  Colistin resistance among blood culture isolates at a tertiary care centre in Hungary. , 2017, Journal of global antimicrobial resistance.

[13]  Z. Wang,et al.  Detection of mcr-1-Carrying Escherichia coli Causing Bloodstream Infection in a New York City Hospital: Avian Origins, Human Concerns? , 2017, Open forum infectious diseases.

[14]  F. Comandatore,et al.  Three cases of mcr-1-positive colistin-resistant Escherichia coli bloodstream infections in Italy, August 2016 to January 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  M. Akova,et al.  Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. , 2017, The Lancet. Infectious diseases.

[16]  Jianzhong Shen,et al.  Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. , 2017, The Lancet. Infectious diseases.

[17]  P. Nordmann,et al.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes , 2017, Clinical Microbiology Reviews.

[18]  D. Hurley,et al.  Multidrug-Resistant Escherichia coli in Bovine Animals, Europe , 2016, Emerging infectious diseases.

[19]  P. Nordmann,et al.  Screening of plasmid-mediated MCR-1 colistin-resistance from bacteremia , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[20]  P. Nordmann,et al.  Plasmid-Mediated Colistin-Resistant Escherichia coli in Bacteremia in Switzerland. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  R. Kaas,et al.  Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  Jianzhong Shen,et al.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. , 2015, The Lancet. Infectious diseases.

[23]  J. Bugert,et al.  Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 , 2015, Emerging infectious diseases.

[24]  Serge Morand,et al.  Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..

[25]  J. van der Palen,et al.  Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit , 2013, Antimicrobial Agents and Chemotherapy.

[26]  T. Johnson,et al.  Plasmid Replicon Typing of Commensal and Pathogenic Escherichia coli Isolates , 2007, Applied and Environmental Microbiology.

[27]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[28]  T. Pál,et al.  Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman. , 2017, Microbial drug resistance.